Mechanisms of plaque vulnerability and rupture
- PMID: 12644336
- DOI: 10.1016/s0735-1097(02)02834-6
Mechanisms of plaque vulnerability and rupture
Abstract
Rupture of atherosclerotic plaque has been identified as the proximate event in the majority of cases of acute ischemic syndromes. Plaque rupture exposes thrombogenic components of the plaque, activating the clotting cascade and promoting thrombus formation. Future culprit lesions are difficult to identify, however, and angiographic assessment of stenosis severity is prone to underestimation. Compared with plaques that cause severe luminal stenosis, vulnerable plaques may cause relatively minor stenosis, although they account for more cases of rupture and thrombosis. Such unstable, vulnerable plaques may be associated with outward remodeling of the vessel. Because severely stenotic plaques are more likely to stimulate collateral circulation to the post-stenotic segment, plaque rupture and thrombosis at such sites may be clinically silent. Characteristic histomorphologic features of vulnerable plaques include a high lipid content, increased numbers of inflammatory cells, and extensive adventitial and intimal neovascularity. The fibrous cap of an atherosclerotic plaque may become thin and rupture as a result of the depletion of matrix components through the activation of enzymes, such as matrix-degrading proteinases and cystine and aspartate proteases, and through the reduction in the number of smooth muscle cells. Activated T cells may also inhibit matrix synthesis through the production of interferon-gamma. A number of triggers of plaque rupture have been identified. Also, some thrombi may occur without rupture of the fibrous cap. Reducing the lipid component and inflammation in atherosclerotic plaques may help reduce the risk of plaque rupture. This may account for the clinical benefit of risk-factor reduction gained from changes in lifestyle and from drug therapy.
Similar articles
-
Inflammation and plaque vulnerability.Cardiovasc Drugs Ther. 2009 Feb;23(1):31-40. doi: 10.1007/s10557-008-6147-2. Epub 2008 Oct 24. Cardiovasc Drugs Ther. 2009. PMID: 18949542 Review.
-
Plaque pathology and coronary thrombosis in the pathogenesis of acute coronary syndromes.Scand J Clin Lab Invest Suppl. 1999;230:3-11. Scand J Clin Lab Invest Suppl. 1999. PMID: 10389196 Review.
-
Plaque disruption and thrombosis: potential role of inflammation and infection.Cardiol Rev. 2000 Jan-Feb;8(1):31-9. Cardiol Rev. 2000. PMID: 11174871 Review.
-
Coronary plaque erosion without rupture into a lipid core. A frequent cause of coronary thrombosis in sudden coronary death.Circulation. 1996 Apr 1;93(7):1354-63. doi: 10.1161/01.cir.93.7.1354. Circulation. 1996. PMID: 8641024 Review.
-
Role of inflammation and metalloproteinases in plaque disruption and thrombosis.Vasc Med. 1998;3(3):199-206. doi: 10.1177/1358836X9800300304. Vasc Med. 1998. PMID: 9892512 Review.
Cited by
-
Evaluation of atherosclerotic lesions using dextran- and mannan-dextran-coated USPIO: MRI analysis and pathological findings.Int J Nanomedicine. 2012;7:2271-80. doi: 10.2147/IJN.S29417. Epub 2012 May 3. Int J Nanomedicine. 2012. PMID: 22619561 Free PMC article.
-
Smad3 regulates smooth muscle cell fate and mediates adverse remodeling and calcification of the atherosclerotic plaque.Nat Cardiovasc Res. 2022 Apr;1(4):322-333. doi: 10.1038/s44161-022-00042-8. Epub 2022 Apr 13. Nat Cardiovasc Res. 2022. PMID: 36246779 Free PMC article.
-
Humanin, a cytoprotective peptide, is expressed in carotid atherosclerotic [corrected] plaques in humans.PLoS One. 2012;7(2):e31065. doi: 10.1371/journal.pone.0031065. Epub 2012 Feb 6. PLoS One. 2012. PMID: 22328926 Free PMC article.
-
A Systematic Review and Meta-Analysis of the Relationship between Receiving the Flu Vaccine with Acute Cerebrovascular Accident and Its Hospitalization in the Elderly.Biomed Res Int. 2023 Feb 13;2023:2606854. doi: 10.1155/2023/2606854. eCollection 2023. Biomed Res Int. 2023. PMID: 36814798 Free PMC article. Review.
-
Assessment of superficial coronary vessel wall deformation and stress: validation of in silico models and human coronary arteries in vivo.Int J Cardiovasc Imaging. 2018 Jun;34(6):849-861. doi: 10.1007/s10554-018-1311-7. Epub 2018 Feb 3. Int J Cardiovasc Imaging. 2018. PMID: 29397475
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous